Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities

被引:3
作者
Gunadi, Christian [1 ]
Shi, Yuyan [1 ]
机构
[1] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA
关键词
Health policy; regulation; Substance abuse; Observational data; quasi-experiment; IMPACT; DEATH;
D O I
10.1186/s12889-023-16256-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundWhile the mandate to check patients' prescription history in Prescription Drug Monitoring Program (PDMP) database before prescribing/dispensing controlled drugs has been shown to be an important tool to curb opioid abuse, less is known about whether the mandate can reduce the misuse of other commonly abused prescription drugs. We examined whether PDMP use mandates were associated with changes in prescription stimulant and depressant quantities.MethodsUsing data from Automated Reports and Consolidate Ordering System (ARCOS), we employed difference-in-differences design to estimate the association between PDMP use mandates and prescription stimulant and depressant quantities in 50 U.S. states and the District of Columbia from 2006 to 2020. Limited PDMP use mandate was specific only to opioids or benzodiazepines. Expansive PDMP use mandate was non-specific to opioid or benzodiazepine and required prescribers/dispensers to check PDMP when prescribing/dispensing targeted controlled substances in Schedule II-V. The main outcomes were population-adjusted prescription stimulant (amphetamine, methylphenidate, lisdexamfetamine) and depressant (amobarbital, butalbital, pentobarbital, secobarbital) quantities in grams.ResultsThere was no evidence that limited PDMP use mandate was associated with a reduction in the prescription stimulant and depressant quantities. However, expansive PDMP use mandate that was non-specific to opioid or benzodiazepine and required prescribers/dispensers to check PDMP when prescribing/dispensing targeted controlled substances in Schedule II-V was associated with 6.2% (95% CI: -10.06%, -2.08%) decline in prescription amphetamine quantity.ConclusionExpansive PDMP use mandate was associated with a decline in prescription amphetamine quantity. Limited PDMP use mandate did not appear to change prescription stimulant and depressant quantities.
引用
收藏
页数:10
相关论文
共 50 条
[21]   Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages [J].
Haffajee, Rebecca L. ;
Mello, Michelle M. ;
Zhang, Fang ;
Zaslavsky, Alan M. ;
Larochelle, Marc R. ;
Wharam, J. Frank .
HEALTH AFFAIRS, 2018, 37 (06) :964-974
[22]   Must-access prescription drug monitoring programs and retail opioid sales [J].
Shakya, Shishir ;
Hodges, Collin .
CONTEMPORARY ECONOMIC POLICY, 2023, 41 (01) :146-165
[23]   A qualitative analysis of prescribers' and dispensers' views on improving prescription drug monitoring programs [J].
Carnes, Neal A. ;
Wright, Eric R. ;
Norwood, Connor W. .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2017, 13 (06) :1167-1174
[24]   Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians [J].
Bao, Yuhua ;
Pan, Yijun ;
Taylor, Aryn ;
Radakrishnan, Sharmini ;
Luo, Feijun ;
Pincus, Harold Alan ;
Schackman, Bruce R. .
HEALTH AFFAIRS, 2016, 35 (06) :1045-1051
[25]   Characteristics of state prescription drug monitoring programs: a state-by-state survey [J].
Manasco, A. Travis ;
Griggs, Christopher ;
Leeds, Rebecca ;
Langlois, Breanne K. ;
Breaud, Alan H. ;
Mitchell, Patricia M. ;
Weiner, Scott G. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (07) :847-851
[26]   What do PAs need to know about prescription drug monitoring programs? [J].
Mospan, Geoffrey A. ;
Lucas, Austin .
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2017, 30 (07) :11-12
[27]   Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses A Systematic Review [J].
Fink, David S. ;
Schleimer, Julia P. ;
Sarvet, Aaron ;
Grover, Kiran K. ;
Delcher, Chris ;
Castillo-Carniglia, Alvaro ;
Kim, June H. ;
Rivera-Aguirre, Ariadne E. ;
Henry, Stephen G. ;
Martins, Silvia S. ;
Cerda, Magdalena .
ANNALS OF INTERNAL MEDICINE, 2018, 168 (11) :783-+
[28]   Barriers to Increasing Prescription Drug Monitoring Program Use A Multidisciplinary Perspective [J].
Marie, Barbara J. St J. ;
Witry, Matthew J. ;
Reist, Jeffrey C. .
CIN-COMPUTERS INFORMATICS NURSING, 2023, 41 (08) :556-562
[29]   Nonmedical Prescription Drug Use Among Injection Drug Users [J].
Martinez, Alexis N. ;
D'Amico, Elizabeth J. ;
Kral, Alex H. ;
Bluthenthal, Ricky N. .
JOURNAL OF DRUG ISSUES, 2012, 42 (03) :216-225
[30]   Effect of Prescription Drug Coverage on the Elderly's Use of Prescription Drugs [J].
Khan, Nasreen ;
Kaestner, Robert .
INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2009, 46 (01) :33-45